Evaluation of the Combination of HDACi and IL-21 in TIL Initial Phase of Expansion

Authors

Joshua Shuren Ni, The Johns Hopkins UniversityFollow
Tamara Griffiths, The University of Texas MD Anderson Cancer Center
Marie-Andree Forget, The University of Texas MD Anderson Cancer Center
Donastas Sakellariou-Thompson, The University of Texas MD Anderson Cancer Center
Chantale Bernatchez, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

Adoptive Cell Therapy, T cells, TIL

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

CPRIT-CURE Summer Undergraduate Program

Recommended Citation

Ni, Joshua Shuren; Griffiths, Tamara; Forget, Marie-Andree; Sakellariou-Thompson, Donastas; and Bernatchez, Chantale, "Evaluation of the Combination of HDACi and IL-21 in TIL Initial Phase of Expansion" (2021). Summer Experience 2021. 13.
https://openworks.mdanderson.org/sumexp21/13